TechBio France 2024 was the inaugural national event dedicated to the French TechBio ecosystem. Organized by WhiteLab Genomics with support from AI for Health, France Biotech, France Deeptech, and Future4Care, TechBio France highlighted the sector’s rapid growth, its potential to revolutionize healthcare innovation, and opportunities for investment.
GenoTher Biocluster
As a GenoTher industry partner, we’re advancing gene therapy innovation through integrating our AI-driven innovation with Genethon’s pioneering research. Together, we overcome challenges in gene delivery, regulatory science, and manufacturing for next-generation therapies.
WIDGeT Consortium
The WIDGeT Consortium, a collaboration between Sanofi, WhiteLab, the TaRGeT Laboratory at Nantes University, and Institut Imagine, was established to optimize AAV-based gene therapies for both rare and common diseases, including age-related macular degeneration and hereditary podocytopathies.
NIIMBL Consortium
We are proud to be a member of the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL), a consortium driving the future of biopharmaceutical manufacturing. Through NIIMBL, we contribute to the development and adoption of next-generation technologies that enhance efficiency, innovation, and patient well-being.
NIST Genome Editing Consortium
As part of the National Institute of Standards and Technology’s (NIST) Genome Editing Consortium, we collaborate with stakeholders in industry, academia, and government to establish rigorous standards and measurement solutions, which are essential for advancing genome editing with precision and reliability.
